The example of search strategy

Slides:



Advertisements
Similar presentations
Prognostic role of caveolin in breast cancer: A meta-analysis Ma X et al., Prognostic role of caveolin in breast cancer: A meta-analysis The Breast (2013)
Advertisements

Hunter, D.J., et al. Cohort studies of fat intake and the risk of breast cancer -- a pooled analysis. New England Journal of Medicine. 1996; 334:
Lymphadenectomy in Epithelial Ovarian Cancer
Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCC’s TNM staging system on overall survival of Caucasian females with breast cancer.
Snyder D, Heidel RE, Panella T, Bell J, Orucevic A University of Tennessee Medical Center – Knoxville Departments of Pathology, Surgery, and Medicine BREAST.
Introduction Patients and Methods Results Conclusion Pericytes are a key component in the maturation of the VEGF driven tumor angiogenic process 1. Bevacizumab.
Jin MENG Shen FU (DPD 08) Biology 2 - Head/Neck and CNS Tumors
Fig A. HRs with 95% CIs for age at menarche (per 1 year increase) on overall survival by clinicopathological subgroups.
Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic.
Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer  Wu-Wei Lai, MD, Fen-Fen Chen, MD,
Prognostic significance of tumor subtypes in male breast cancer:
Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive.
Immunoscore Prognostic in Colon Cancer
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
Fig 1A. Patient enrollment flow chart
Promoter polymorphisms of the SWI/SNF chromatin remodeling complex molecule, BRM and esophageal adenocarcinoma outcome Grzegorz Korpanty1, Xin Qiu1, Lawson.
TBCRC (the translational breast cancer research consortium) 005 Prospective study
Mansoura University, Mansoura, Egypt
Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: Influence of Prognostic Factors of Survival J Tabernero,
Supporting Information for Meta-analysis
Does Adenomyosis Impede Spread of Endometrial Cancer
Supporting Information for Meta-analysis
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
سرطان الثدي Breast Cancer
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Multivariable model of abatacept retention in biologic-naïve patients.
High retinoblastoma (RB) expression is prevalent in human pancreatic ductal adenocarcinoma (PDA) and is of prognostic relevance in independent cohorts.
PARPi combinations against HR-proficient tumors.
Shidan Wang, BS, Lin Yang, MD, Bo Ci, BS, Matthew Maclean, BS, David E
Patients who have received chemotherapy (n=60)
Disease-specific survival
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
PRISMA study flow diagram
Kaplan-Maier survival curves of 10-year DFS (A and B) and OS (C and D) according to PS 0 and PS≥1 in patients treated with adjuvant chemotherapy after.
A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage.
ROC curve for separating advanced stages (advanced BE and EA) versus early stages (BE or BE instability) using total genome-wide LOH [area under the curve.
Baseline Characteristics According to Sex
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group by Tao Wu, Yong Yang, Su-Yu.
Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer  Wu-Wei Lai, MD, Fen-Fen Chen, MD,
High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma  Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.
高雄榮民總醫院耳鼻喉頭頸部 林陞樵 林曜祥 康柏皇 張庭碩
Uni- & Multivariate Analysis Sponsored by GERCOR (
Principal component analysis of adipose tissue fatty acids.
Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local.
GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR
Age-adjusted OR (A) and multivariate-adjusted OR (B) and 95% CI for the presence of retinopathy and albuminuria by quintiles of WBC count in 3,776 patients.
HRs for prostate cancer by medication status.
Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma  Qingyuan.
Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value, Area Under the Curve, and 95% CIs for the 0, 10, 25, 50, and 100 SatSeconds.
Adjusted HRs (95% CIs) for all-cause mortality associated with BMI by smoking status in men and women and by CHD, type 2 diabetes, and cancer status at.
Adjusted HRs (95% CIs) for all-cause mortality associated with body fat percentage by smoking status in men and women and by CHD, type 2 diabetes, and.
MiR-520d-3p is an independent positive prognostic factor in ovarian cancer. miR-520d-3p is an independent positive prognostic factor in ovarian cancer.
Meta-analysis of five prospective studies examining the associations between urinary melatonin secretion and breast cancer risk. Meta-analysis of five.
Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.
Multivariate-adjusted breast density means for joint relation of IGF-I with IGFBP-3 in premenopausal women. Multivariate-adjusted breast density means.
Risk (aOR) of breast cancer associated with the combination of putative at-risk genotypes of the MRN genes and the reproductive risk factors of a history.
Age-adjusted breast cancer incidence rates in females by age-adjusted HD incidence rates in females 15–34 years of age in 135 populations in the world.
Kaplan–Meier curves for PFS and OS (for patients treated with anti-PD-1/PD-L1 monotherapy). Kaplan–Meier curves for PFS and OS (for patients treated with.
The ROC curves analyzing the sensitivity and specificity of rCBVmax values in astrocytomas for 1-year survival (A) and recurrence (B) show the optimal.
A and B, The ROC curves analyzing the sensitivity and specificity of the WHO grading system (I-IV) for the 1-year survival (A) and recurrence (B) show.
Scatter plot of serum OPN levels and its correlation with patient survival. Scatter plot of serum OPN levels and its correlation with patient survival.
RR (with 95% CI) of total mortality (multivariate-adjusted) by duration of smoking cessation among diabetic women. RR (with 95% CI) of total mortality.
Association of overall survival and PAP-specific (A, B) and PA2024-specific (C, D) CTL activity at week 26 using categorical (tertile) analysis and continuous.
(A) Survival curves according to clinical response.
Survival RR enhancement according to the specific protocol in treated mice. Survival RR enhancement according to the specific protocol in treated mice.
Progression and survival analysis.
Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma  Wei-Wei Chen, MD, Feng Wang, MD, PhD, ShaoBin Chen, MD, Luhua Wang,
Volume 20, Issue 8, Pages (August 2019)
median of follow-up (month)
Meta-analysis of the effect of gender in the overall survival, comparing HRs and 95% CI obtained from multivariate analysis in hospital databases. Meta-analysis.
Presentation transcript:

The example of search strategy Title:Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients:a Systematic Review and Meta-analysis (PONE-D-15-14796) Author:Fanghui Ren, Ruixue Tang, Xin Zhang, Wickramaarachchi Mihiranganee Madushi, Dianzhong Luo, Yiwu Dang, Zuyun Li, Kanglai Wei, Gang Chen * 2015/07/13

Search strategy

Search strategy

The information reported in the study Age and follow-up time Method

The information reported in the study NO. of MMP-9 positive Tumour size nodal status TNM Stage

HR and 95%CI reported in the study RR and 95CI%

HR and 95%CI calculated by K-M survival curve The study reported by Pellikainen et al.

HR and 95%CI calculated by K-M survival curve

HR and 95%CI calculated by K-M survival curve

HR and 95%CI calculated by K-M survival curve

HR and 95%CI calculated by K-M survival curve

HR and 95%CI calculated by K-M survival curve

HR and 95%CI calculated by K-M survival curve

HR and 95%CI calculated by K-M survival curve

HR and 95%CI calculated by K-M survival curve

OS (all relevant studies analyzed by univariate analysis)

OS (all relevant studies analyzed by univariate analysis)

OS (all relevant studies analyzed by univariate analysis)

OS (all relevant studies analyzed by univariate analysis)

OS (all relevant studies analyzed by univariate analysis)

OS(all relevant studies analyzed by univariate analysis after sensitivity analysis)

OS(all relevant studies analyzed by univariate analysis after sensitivity analysis)

OS(all relevant studies analyzed by multivariate analysis)

OS(all relevant studies analyzed by multivariate analysis)

OS of MMP-9(all relevant studies analyzed by univariate analysis)

OS of MMP-9(all relevant studies analyzed by univariate analysis)

OS of MMP-9(all relevant studies analyzed by univariate analysis after sensitivity analysis)

OS of MMP-9(all relevant studies analyzed by univariate analysis after sensitivity analysis)

OS of MMP-9(all relevant studies analyzed by multivariate analysis )

OS of MMP-9(all relevant studies analyzed by multivariate analysis )

RFS(all relevant studies )

RFS(all relevant studies )

Thank you very much